The association between metabolic syndrome and infarct size in patients with acute myocardial infarction

References

• Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, Salonen JT. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002;288:2709–16.
   PubMed Web of Science ®Google Scholar
• Ninomiya JK, L’Italien G, Criqui MH, Whyte JL, Garnst A, Chen RS. Association of the metabolic syndrome with history of myocardial infarction and stroke in the Third National health and Nutrition Examination Survey. Circulation 2004; 109:42–6.
   PubMed Web of Science ®Google Scholar
• Reaven GM. Banting lecture 1988: role of insulin resistance in human disease. Diabetes 1988;37:1595–607.
   PubMed Web of Science ®Google Scholar
• Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation 2002;106: 3143–421.
   PubMed Web of Science ®Google Scholar
• Girman CJ, Rhodes T, Mercuri M, Pvörälä K, Kjekshus J, Pedersen TR, Beere PA, Gotto AM, Clearfield M. 4S Group and the AFCAPS/TexCAPS Research Group. The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). Am J Cardiol 2004;93:136–41.
   PubMed Web of Science ®Google Scholar
• Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, Taskinen MR, Groop L. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001;24:683–9.
   PubMed Web of Science ®Google Scholar
• Malik S, Wong ND, Franklin SS, Kamath TV, L’Italien GJ, Pio JR, Williams GR. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 2004;110: 1245–50.
   PubMed Web of Science ®Google Scholar
• Gami AS, Witt BJ, Howard DE, Erwin PJ, Gami LA, Somers VK, Montori VM. Metabolic syndrome and risk of incident cardiovascular events and death. J Am Coll Cardiol 2007;49:403–14.
   PubMed Web of Science ®Google Scholar
• Takeno M, Yasuda S, Otsuka Y, Morii I, Kawamura A, Yano K Miyazaki S. Impact of metabolic syndrome on the long-term survival of patients with acute myocardial infarction. Potential association with C-reactive protein. Circ J 2008;72:415–9.
   PubMed Web of Science ®Google Scholar
• Zeller M, Steg PG, Ravisy J, Laurent Y, Janin-Magnificat, L’Hullier I, Beer J-C, Oudot A, Rioufol G, Makki H, Farnier M, Rochette L, Vergès B, Cottin Y. Prevalence and impact of metabolic syndrome on hospital outcomes in acute myocardial infarction. Arch Intern Med 2005;165:1192–8.
   PubMedGoogle Scholar
• Birhan Yilmaz M, Guray U. Guray Y, Altay H, Demirkan B, Caldir V, Cay S, Refiker ME, Sasmaz H, Korkmaz S. Metabolic syndrome is associated with extension of coronary artery disease in patients with non-ST segment elevation acute coronary syndromes. Coronary Artery Disease 2005; 16:287–92.
   PubMedGoogle Scholar
• Burns RJ, Gibbons RJ, Yi Q, Roberts RS, Miller TD, Schaer GL, Anderson JL, Yusuf S; CORE Study Investigators. The relationship of left ventricular ejection fraction, end-systolic volume index and infarct size to six-month mortality after hospital discharge following myocardial infarction treated by thrombolysis. J Am Coll Cardiol 2002;39: 30–6.
   PubMedGoogle Scholar
• Miller TD, Christian TF, Hopfenspirger MR, Hodge DO, Gersh BJ, Gibbons RJ. Infarct size after acute myocardial infarction measured by quantitative tomographic 99m Tc sestamibi imaging predicts subsequent mortality. Circulation 1995;92:334–41.
   PubMed Web of Science ®Google Scholar
• Yilmaz MB, Caldir V, Guray Y, Guray U, Altay H, Demirkan B, Cay S, Kisacik HL, Korkmaz S. Relation of coronary collateral vessel development in patients with a totally occluded right coronary artery to the metabolic syndrome. Am J Cardiol 2006;97:636–9.
   PubMedGoogle Scholar
• Gonon AT, Widegren U, Bulhak A, Salehzadeh F, Persson J, Sjöquist PO, Pernow J. Adiponectin protects against myocardial ischemia-reperfusion injury via AMP-activated protein kinase, Akt, and nitric oxide. Cardiovasc Res 2008; 78:116–22.
   PubMed Web of Science ®Google Scholar
• Thim T, Bentzon JF, Kristiansen SB, Simonsen U, Andersen HL, Wassermann K, Falk E. Size of myocardial infarction induced by ischemia/reperfusion is unaltered in rats with metabolic syndrome. Clin Sci 2006;110:665–71.
   Google Scholar
• Solskov L, Løfgren B, Pold R, Kristiansen SB, Nielsen TT, Overstreet DH, Schmitz O, Bøtker HE, Lund S, Wegener G. Evaluation of the relationship between hyperinsulinaemia and myocardial ischemia/reperfusion injury in rat model of depression. Clin Sci 2010;118:259–67.
   Google Scholar
• Clavijo LC, Pinto TL, Kuchulakanti PK, Torguson R, Chu WW, Satler LF, Kent KM, Suddath WO, Pichard AD, Waksman R. Metabolic syndrome in patients with acute myocardial infarction is associated with increased infarct size and in-hospital complications. Cardiovasc Revasc Med 2006;7:7–11.
   PubMedGoogle Scholar
• Palomo I, Alarcón M, Moore-Carrasco R, Argilés JM. Hemostasis alterations in metabolic syndrome. Int J Mol 2006;18:969–74.
   PubMed Web of Science ®Google Scholar
• Hajer GR, Van Haeften TW, Visseren FLJ, Adipose tissue dysfunction in obesity, diabetes and vascular diseases. Eur Heart J 2008;29:2959–71.
   PubMed Web of Science ®Google Scholar
• Troseid M, Seljeflot I, Hjerkinn EM, Arnesen H. Interleukin-18 is a strong predictor of cardiovascular events in elderly men with the metabolic syndrome. Synergistic effect of inflammation and hyperglycemia. Diabetes Care 2009; 32:486–92.
   PubMed Web of Science ®Google Scholar
• Bohmer E, Hoffmann P, Abdelnoor M, Arnesen H, Halvorsen S. Efficacy and safety of immediate angioplasty versus ischemia guided management after thrombolysis in acute myocardial infarction in areas with very long transfer distances. J Am Coll Cardiol 2010;55:102–10.
   PubMed Web of Science ®Google Scholar
• Sadowski EA, Bennett LK, Chan MR, Wentland AL, Garret AL, Garret RW, Djamali A. Nephrogenic systemic fibrosis: risk factors and incidence estimation. Radiology 2007;243:148–57.
   PubMed Web of Science ®Google Scholar
• Hoffmann P, Halvorsen S, Stensæth K-H, Brekke M, Müller C, Anker GO, Abdelnoor M, Kløv NE. Myocardial perfusion in ST-elevation myocardial infarction treated successfully with primary angioplasty. Scand Cardiovasc J 2006; 40:96–104.
   PubMed Web of Science ®Google Scholar
• Kirkwood BR, Sterne JAC. Essentials of medical statistics science, 2nd, Massachusetts, USA: Blackwell Science Ltd, 2003.
   Google Scholar
• Thanavaro S, Kleiger RE, Province MA, Hubert JW, Miler JP, Krone RJ, Oliver GC. Effect of infarct location on the in-hospital prognosis of patients with first transmural myocardial infarction. Circulation 1982;66:742.
   PubMedGoogle Scholar
• Christian TF, Schwartz RS, Gibbons RJ. Determinants of infarct size in reperfusion therapy for acute myocardial infarction. Circulation 1992;86:81–90.
   PubMed Web of Science ®Google Scholar
• Timmer JR, van der Horst IC, Ottervanger JP, Henriques JP, Hoorntje JC, de Boer MJ, Suryapranata H, Zijlstra F, Zwolle Myocardial Infarction Study Group. Prognostic value of admission glucose in non-diabetic patients with myocardial infarction. Am Heart J 2004;148:399–404.
   PubMedGoogle Scholar
• Alberti KG, Zimmel P, Shaw J. The metabolic syndrome – a new worldwide definition. Lancet 2005;366:1059–62.
   PubMed Web of Science ®Google Scholar
• Feinberg MS, Schwartz R, Tanne D, Fisman EZ, Hod H, Zagher D, Schwammethal E, Eldar M, Behar S, Tenenbaum A. Impact of the metabolic syndrome on the clinical outcomes of non-clinically diagnosed diabetic patients with acute coronary syndrome. Am J Cardiol 2007; 99:667–72.
   PubMedGoogle Scholar
• Yusuf S, Hawken S, Ounpuu S, Bautista L, Franzosi MG, Commerford P, Lang CC, Rumboldt Z, Onen CL, Lisheng L, Tanomsup S, Wangai P Jr, Razak F, Sharma AM, Anand SS, INTERHEART Study Investigators. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet 2005: 366:1640–9.
   PubMed Web of Science ®Google Scholar